During the past decade, Ospedale di Manerbio conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale di Manerbio" #1 collaborator was "Federation of Italian Cooperative Oncology Groups" with 1 trials as a collaborator, "Fondazione Policlinico Universitario Agostino Gemelli IRCCS" with 1 trials as a collaborator and "Istituto Di Ricerche Farmacologiche Mario Negri" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale di Manerbio" are "Heart Failure" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Ospedale di Manerbio" in a lesser frequency.

Most popular intervention types in "Ospedale di Manerbio" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Exemestane" (1 trials), "Placebo" (1 trials), "Placebo oral tablet" (1 trials), "Rosuvastatin" (1 trials) and "n-3 PUFA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale di Manerbio" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale di Manerbio". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ospedale di Manerbio, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale di Manerbio, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".